Article Details

Metacrine (NASDAQ:MTCR) Downgraded by Zacks Investment Research to “Hold”

Retrieved on: 2022-06-02 14:14:02

Tags for this article:

Click the tags to see associated articles and topics

Metacrine (NASDAQ:MTCR) Downgraded by Zacks Investment Research to “Hold”. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 423,100 shares of the company's stock worth $258,000 after buying an additional 193,800 shares during the period ...

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo